HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers ...

HIV drugs can prevent HTLV-1 transmission and disease in mice, paving the way for trials to fight this long-overlooked, ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

Research shows that NRTIs, antiviral drugs used for HIV, could prevent Alzheimer's by blocking inflammasomes, offering a promising path for drug repurposing.

HIV drugs stopped for millions by USAID cuts – this is the drastic effect it could have on their health - A generation has passed since the peak in AIDS-related deaths ...

Gilead said Thursday that its twice-yearly antiviral reduced the risk of HIV infections by 96% compared to an expected rate of infection in a second pivotal trial, paving the way for the likely ...

Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Yeztugo was approved by the FDA ...

G ilead said Thursday that twice-a-year injections of a new antiviral drug, called lenacapavir, completely protected cisgender women from contracting HIV in a large Phase 3 trial. In the study ...